Second tenofovir phase III study for the chronic HBV reaches primary endpoint.
出版信息
AIDS Patient Care STDS. 2007 Aug;21(8):607-8.
PMID:17907310
Abstract
摘要
相似文献
1
Second tenofovir phase III study for the chronic HBV reaches primary endpoint.
AIDS Patient Care STDS. 2007 Aug;21(8):607-8.
2
Raltegravir as effective as efavirenz in 144-week data.在144周的数据中，拉替拉韦与依非韦伦疗效相当。
AIDS Patient Care STDS. 2009 Aug;23(8):679-80.
3
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].一名感染艾滋病毒的女性患者出现对替诺福韦的超敏反应（药物超敏反应伴嗜酸性粒细胞增多和全身症状综合征）
Med Mal Infect. 2013 Mar;43(3):134-5. doi: 10.1016/j.medmal.2013.01.008. Epub 2013 Feb 20.
4
Elvucitabine data released at CROI.在逆转录病毒和机会性感染会议（CROI）上公布的elvucitabine数据。
AIDS Patient Care STDS. 2010 Mar;24(3):198.
5
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.替诺福韦酯与阿德福韦酯治疗慢性乙型肝炎的比较
N Engl J Med. 2008 Dec 4;359(23):2442-55. doi: 10.1056/NEJMoa0802878.
6
Two-year data released on Viread for chronic hepatitis B.
AIDS Patient Care STDS. 2008 Nov;22(11):921. doi: 10.1089/apc.2008.9938.
7
Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication.用阿德福韦替代替诺福韦可能导致乙型肝炎病毒复制重新激活。
Scand J Gastroenterol. 2006 Feb;41(2):245-6. doi: 10.1080/00365520500319013.
8
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction.替诺福韦与阿巴卡韦对HIV相关内皮功能障碍的影响。
AIDS Patient Care STDS. 2011 Oct;25(10):567-9. doi: 10.1089/apc.2011.0184. Epub 2011 Aug 18.
9
[The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].[首个获批的核苷酸类似物。新型乙肝治疗方法也有助于问题患者]
MMW Fortschr Med. 2003 Jun 12;145(24):52.
10
[Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors].[临床数据I. 替诺福韦与非核苷类逆转录酶抑制剂联合使用的临床经验]
Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:7-12. doi: 10.1157/13126266.
Zotero 插件